Antimicrobial Susceptibility Trends among Staphylococcus aureus Isolates from U.S. Hospitals: Results from 7 Years of the Ceftaroline (AWARE) Surveillance Program, 2010 to 2016.

Sader, Helio S

Antimicrobial Susceptibility Trends among Staphylococcus aureus Isolates from U.S. Hospitals: Results from 7 Years of the Ceftaroline (AWARE) Surveillance Program, 2010 to 2016. [electronic resource] - Antimicrobial agents and chemotherapy 09 2017

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1098-6596

10.1128/AAC.01043-17 doi


Anti-Bacterial Agents--therapeutic use
Cephalosporins--therapeutic use
Clindamycin--therapeutic use
Erythromycin--therapeutic use
Humans
Levofloxacin--therapeutic use
Methicillin-Resistant Staphylococcus aureus--drug effects
Microbial Sensitivity Tests--trends
Staphylococcal Skin Infections--drug therapy
Tetracycline--therapeutic use
Trimethoprim, Sulfamethoxazole Drug Combination--therapeutic use
United States
Ceftaroline